Top Biotech Companies (3,705)
Farcast is human tumor microdynamics platform that predicts clinical response based on data from live human tumors. Our mission is to tell the truth about every patient tumor, every time and help improve outcomes for cancer patients.
Koligo therapeutics is a transformational cell therapies for patients with pancreatic disease .
Neuroinitiative is dedicated to the advancement of research and understanding two neurodegenerative disorders, Alzheimer’s & Parkinson’s
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives...
Vivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B system.
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
ENBIOSIS Biosciences reaches deep into your inner world with microbiome analysis and offers you the key for a sustainable and healthy life
Avioq is an in vitro diagnostic medical device manufacturer and a contract development, contract manufacturing organization. Based in Research Triangle Park, North Carolina Avioq has a FDA licensed manufacturing facility and large, modern R&D laboratories. Our products include an FDA licensed HTLV-I/II assay for screening serum and plasma from blood donor and cadaveric samples, which also has CE marking and Health Canada...
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating...
Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions that are not adequately addressed by current treatments. For more information, please visit www.hemostemix.com.
Emerald Heath Pharmaceuticals is a biotech company developing novel therapies for neurodegenerative and autoimmune diseases. Including multiple sclerosis, systemic sclerosis (a form of scleroderma), Parkinson's disease and Huntington's disease. References/Sources: - National Multiple Sclerosis Society - Parkinson’s Foundation - Huntington’s Disease Society of America - Scleroderma Foundation - Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Omeros is a Seattle-based commercial-stage biopharmaceutical company that discovers, develops, and commercializes first-in-class small-molecule and protein therapeutics for large-market and orphan indications. Its programs focus on complement-mediated diseases, inflammation, cancers, and addictive or compulsive disorders. The company’s pipeline includes FDA-approved YARTEMLEA, the investigational MASP-2 inhibitor OMS1029, OMS527 in clinical development, and a growing portfolio of molecular and cellular oncology programs.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts,...
Alcon's Top Stability & Growth Strengths
Strong Market Position & Advantage: The business is positioned as a global leader in eye care with meaningful share in contact lenses and one of the largest installed bases in ophthalmic surgical equipment, supporting durable demand across geographies. Scale across Vision Care and Surgical also supports recurring revenue via consumables tied to the installed base.
Resilient & Sustainable Growth: Revenue is described as growing year over year with guidance calling for continued mid-single-digit constant-currency sales growth into 2026, supported by steady demand for essential procedures like cataract surgery. The company is also positioned to outpace broader eye-care market growth expectations per the provided outlook.
Healthy Cash Flow: Cash generation is described as strong, with operating cash flow and free cash flow at sizable levels that support ongoing investment and shareholder returns. This cash profile provides resilience against near-term cost headwinds and funding for launches and efficiency programs.
Alcami is a US-based contract development, testing, and manufacturing organization for pharma and biotech companies. Since 1979, we support our clients in making their projects go from potential to reality day-after-day. Alcami recently announced the acquisition of Masy BioServices. Masy offers secure and tightly controlled GMP temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including...
ChemImage Corporation is committed to making the world healthier and safer through dramatic advancements in chemical imaging technologies. The company’s proprietary chemical imaging sensors, algorithms, and analysis software enable life sciences and medical device companies, defense and security organizations, and computer vision professionals to solve challenging health and safety issues. With performance-leading chemical imaging technology, ChemImage strives to provide people...
Our platforms use silicon nanopore chips and proprietary biochemistry to accurately detect and differentiate single molecules. We will help transform point-of-care testing and third generation sequencing.
Chemily, LLC specializes in cost-effective synthesis of glycan libraries, carbohydrate-based biochemicals, reagents and pharmaceuticals.
We create materials at the intersection of art, nature and biotechnology using mycelium, one of the earth’s most regenerative resources. Our mission is to create a platform for the highest quality materials using Fine Mycelium™. Our first product, Reishi™ offers our partners in fashion an option for leather that is neither animal nor plastic, yet uncompromising in quality and aesthetic...
